A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
Inferred to overlap with: Df(3L)BSC377.
Df(3L)BSC838/+ testes do not show a germline stem cell-like tumor phenotype.
The breakpoints of Df(3L)BSC838 predicted from the Release 5 genomic coordinates of the insertion sites of the progenitor transposable elements PBac{WH}hayf00028 and P{XP}d09684 are 3L:10624606 ;11063626 and the cytological breakpoints predicted from these coordinates are 67E5;68A4.